At the top of this article published in 2024 Physicians Postgraduate Press, Inc and www.psychiatrist.com had this posted at the top of the article
Posting of this PDF is not permitted. | For reprints or permissions, contact
permissions@psychiatrist.com. | © 2024 Physicians Postgraduate Press, Inc.
So I copied ONE PARAGRAPH from the article that seems to plainly describes the target of this article and that is to convince the Psychiatrist’s profession to look at considering putting a DX of OUD ( Opioid Use Disorder) on any pt being prescribed a opioid to treat their chronic pain and they seem to try and create a new disorder POUD (Prescription Opioid Use Disorder). I wonder how long it will take for there to be a ICD-10 code for this “medical issue”
Apparently the medical term POUD was first published in this article in July 2024 Prescription Opioid Use Disorder Among Adults Reporting Prescription Opioid Use With or Without Misuse in the United States https://pubmed.ncbi.nlm.nih.gov/39028542/
and by the title the article the authors of this article appear to create this medical disease was to be DXd to people taking opioids WITH OR WITHOUT MISUSING the OPIOID and in this article there are 34 references. Maybe that is what it takes to try and introduce a NEW DISEASE STATE to be recognized?
I also included the Relevant Financial Relationships of the two authors from the article.
I asked www.perlexity.ai to summarize this article and here is its response:
This article, titled “The Opioid Industry’s Legacy: A Generation of Prescribed Suffering” by Andrew Kolodny and Robert M. Bohler, discusses the far-reaching consequences of the opioid industry’s campaign to increase opioid prescribing in the United States. The authors highlight several key points:
## Underestimation of Opioid Use Disorder (OUD)
The National Survey on Drug Use and Health (NSDUH), the primary tool for measuring OUD prevalence, had a significant flaw that led to a massive undercount of OUD cases[1]. This flaw was influenced by opioid industry messaging, which claimed that OUD was rare in patients taking opioids as prescribed.
## Revised NSDUH Findings
After correcting the methodology, the United States Department of Health and Human Services (HHS) now estimates that:
– 5 million Americans suffer from prescription opioid use disorder (POUD)[1][2]
– This number is more than triple the previous estimate from 2019
– 62% of people with POUD do not misuse their prescription opioids but take them as prescribed[1]
## Physiological Dependence and POUD
The article challenges industry-influenced educational messages that downplay the risk of POUD and the consequences of physiological dependence. Key points include:
– Physiological dependence can develop rapidly, even within the first few days of opioid use
– Opioid withdrawal symptoms can be severe and long-lasting
– The effects of physiological dependence and withdrawal help explain why millions of patients who take opioids as prescribed suffer from POUD
## Industry Influence on Perception
The authors describe how the opioid industry influenced various stakeholders to promote a false narrative about opioid use:
– Academics, professional societies, and journalists with financial ties to opioid manufacturers disseminated misleading information
– The distinction between physiological dependence and addiction was exaggerated
– State medical boards were influenced by industry-funded policies
## Conclusion
The article concludes that many patients prescribed opioids are not benefiting from long-term use but are actually suffering from POUD. The authors argue that these patients are victims of a campaign that promoted aggressive opioid use while minimizing the difficulties of discontinuation.
Citations:
[1] https://ppl-ai-file-upload.s3.amazonaws.com/web/direct-files/29836200/58a4853c-a264-44e1-bd4f-4235ce286a28/paste.txt
[2] https://ppl-ai-file-upload.s3.amazonaws.com/web/direct-files/29836200/2d619b85-40ba-4a8a-94bf-6458ea518a5a/paste-2.txt
www.psychiatrist.com/pdf/the-opioid-industry%ca%bcs-legacy-a-generation-of-prescribed-suffering-pdf/
Recently, in the pages of this journal, we learned that the National Survey on Drug Use and Health (NSDUH), the federal government’s primary tool for measuring the prevalence of OUD, was also influenced by opioid industry messaging. In the article, “Prescription Opioid Use Disorder Among Adults Reporting Prescription Opioid Use With or Without Misuse in the United States” by Han et al,1 the United States Department of Health and Human Services (HHS) acknowledged a serious and long-standing flaw in the NSDUH that led to a massive undercount of OUD. The survey had been systematically excluding patients prescribed opioids from receiving its OUD assessment.
To Cite: Kolodny A, Bohler RM. The opioid industryʼs legacy: a generation of prescribed suffering. J Clin Psychiatry. 2025;86(1):24com15664.
Author Affiliations: Opioid Policy Research Collaborative, The Heller School for Social Policy and Management, Brandeis University, Waltham, Massachusetts (Kolodny); Jiann-Ping Hsu College of Public Health, Georgia Southern University, Statesboro, Georgia (Bohler). Corresponding Author: Andrew Kolodny, MD, 415 South St, MS 035, Waltham, MA 02453 (akolodny@brandeis.edu).
Relevant Financial Relationships: Dr Kolodny has received fees for serving as an expert witness in litigation against the opioid industry and is the president of the nonprofit organization Physicians for Responsible Opioid Prescribing. Dr Bohler has received fees for serving as a research consultant in litigation against the opioid industry.
Filed under: General Problems
This is utter pseudoscience that is intentionally and deliberately designed to further stigmatize chronic pain patients by baselessly categorizing us as being problematic simply because we utilize a certain medical treatment. An act that is phenomenally unique in that no other patient group is unfairly targeted or characterized in such a way, which lends credence to it being more a means of legitimizing discrimination than being of meaningful assistance to the patient in any regard. It’s easy for these people to sit outside of the issue and cast erroneous judgment based solely upon what they think they’re observing through their biased lens of addiction and purported prevention thereof. It amounts to nothing more than a concerted effort to pigeonhole chronic pain patients into a category in which these people have an unwarranted, undeserved degree of power and authority over chronic pain patients, despite completely denying us the opportunity to question their assertions and without the privilege of requiring individual examination or assessment to determine the appropriateness of the label that it readily assigns to us. In other words, it should NEVER be allowed to move forth. This is the epitome of discrimination. It’s unacceptable, intolerable, and something that we should be collectively addressing with urgency before it has time to get a permanent foothold as being legitimate. Because it most certainly is not, and it certainly will further devastate chronic pain patients in a way that will most probably reach far beyond what we can presently imagine. I wish I could say that I am shocked, but sadly, I’m not. They’re not done kicking us while we are already down. In the name of the “opioid crisis”, they’ve found a way to hurt us even more. Absolutely vile.